
Norathyriol | CAS:3542-72-1
Norathyriol
- 名称:降阿赛里奥; 1,3,6,7-四羟基氧杂蒽酮 | Norathyriol
- CAS号:3542-72-1
- 别名:1,3,6,7-Tetrahydroxyxanthone; Mangiferitin
- 分子式:C13H8O6
- 分子量:260.20
- EINESC号:
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Hepatic microsomal thiol methyltransferase is involved in stereoselective methylation of pharmacologically active metabolite of prasugrel.Miho Kazui et al.Drug metabolism and disposition: the biological fate of chemicals, 42(7), 1138-1145 (2014-04-16)
Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry.Nagy A Farid et al.Rapid communications in mass spectrometry : RCM, 21(2), 169-179 (2006-12-13)
Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats.Hongwei Yao et al.Biochemical pharmacology, 180, 114142-114142 (2020-07-13)
Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study.Bogumił Ramotowski et al.Thrombosis and haemostasis, 120(3), 449-456 (2020-01-16)
Arylacetamide Deacetylase Is Involved in Vicagrel Bioactivation in Humans.Jinfang Jiang et al.Frontiers in pharmacology, 8, 846-846 (2017-12-07)
Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study.K E Kristensen et al.Clinical pharmacology and therapeutics, 96(6), 713-722 (2014-09-16)
The influence of genetic polymorphism of Cyp2c19 isoenzyme on the pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.Marta Karaźniewicz-Łada et al.Journal of clinical pharmacology, 54(8), 874-880 (2014-05-02)
Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS.Makoto Takahashi et al.Journal of pharmaceutical and biomedical analysis, 48(4), 1219-1224 (2008-10-03)
Development and validation of a UPLC-MS/MS method for simultaneous determination of vicagrel and its major metabolites in rat or human plasma: An optimized novel strategy for the stabilization of vicagrel.Ting Tai et al.Journal of pharmaceutical and biomedical analysis, 179, 112955-112955 (2019-12-24)
CYP-independent inhibition of platelet aggregation in rabbits by a mixed disulfide conjugate of clopidogrel.H Zhang et al.Thrombosis and haemostasis, 112(6), 1304-1311 (2014-09-19)
Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography/triple quadrupole mass spectrometry.Zhe-Yi Hu et al.Rapid communications in mass spectrometry : RCM, 28(11), 1285-1292 (2014-04-25)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!